Pregnant Women's Experiences of Seeking Treatment for Opioid Use.
Journal
MCN. The American journal of maternal child nursing
ISSN: 1539-0683
Titre abrégé: MCN Am J Matern Child Nurs
Pays: United States
ID NLM: 7605941
Informations de publication
Date de publication:
21 Mar 2024
21 Mar 2024
Historique:
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
aheadofprint
Résumé
The purpose of this study was to describe women's experiences seeking treatment for opioid use disorder during pregnancy. This was an exploratory multi-method study to understand women's experiences seeking treatment for opioid use disorder during pregnancy using surveys and interviews. Women pregnant within the past 5 years while using opioids were recruited from a private Facebook group for mothers on medication for opioid use disorder. Members of this group assisted with the development of the survey. Descriptive statistics were used for the 18-question survey and interviews were recorded, transcribed, and analyzed for themes. Twenty-one women completed an online survey, and six participated in an in-depth virtual interview about their experience. Five themes describing their experiences were identified: (1) fear of child protective services, (2) family and partner support, (3) health care providers' reactions, (4) accessing treatment centers, and (5) awareness of support services during pregnancy. Participants reported an overall negative experience seeking treatment for opioid use disorder during pregnancy. Nurses can improve the outcomes for pregnant women with opioid use disorder by using a non-stigmatizing approach, promoting early identification, and providing information, including harm reduction education. Facilitation of resources for treatment, mother and child programs, and advocating for partner treatment can improve maternal and neonatal outcomes.
Identifiants
pubmed: 38512125
doi: 10.1097/NMC.0000000000001024
pii: 00005721-990000000-00048
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Références
Asta D., Davis A., Krishnamurti T., Klocke L., Abdullah W., Krans E. E. (2021). The influence of social relationships on substance use behaviors among pregnant women with opioid use disorder. Drug and Alcohol Dependence, 222, 108665. https://doi.org/10.1016/j.drugalcdep.2021.108665
doi: 10.1016/j.drugalcdep.2021.108665
Atkins D. N., Durrance C. P. (2020). State policies that treat prenatal substance use as child abuse or neglect fail to achieve their intended goals. Health Affairs, 39(5), 756–763. https://doi.org/10.1377/hlthaff.2019.00785
doi: 10.1377/hlthaff.2019.00785
Bruzelius E., Martins S. S. (2022). US trends in drug overdose mortality among pregnant and postpartum persons, 2017-2020. JAMA, 328(21), 2159–2161. https://doi.org/10.1001/jama.2022.17045
doi: 10.1001/jama.2022.17045
Frazer Z., McConnell K., Jansson L. M. (2019). Treatment for substance use disorders in pregnant women: Motivators and barriers. Drug and Alcohol Dependence, 205, 107652. https://doi.org/10.1016/j.drugalcdep.2019.107652
doi: 10.1016/j.drugalcdep.2019.107652
Harris P. A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J. G. (2009). Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010
doi: 10.1016/j.jbi.2008.08.010
Kim J., Busse M., Kantrowitz-Gordon I., Altman M. R. (2022). Health care experiences during pregnancy and parenting with an opioid use disorder. MCN, The American Journal of Maternal Child Nursing, 47(2), 100–106. https://doi.org/10.1097/NMC.0000000000000805
doi: 10.1097/NMC.0000000000000805
Mazel S., Alexander K., Cioffi C., Terplan M. (2023). Interventions to support engagement in addiction care postpartum: Principles and pitfalls. Substance Abuse and Rehabilitation, 14, 49–59. https://doi.org/10.2147/SAR.S375652
doi: 10.2147/SAR.S375652
National Institute on Drug Abuse. (2022). National institute on drug abuse 2022-2026 strategic plan. https://www.drugabuse.gov/sites/default/files/2016-2020nidastrategicplan.pdf
Patrick S. W., Barfield W. D., Poindexter B. B., Cummings J., Hand I., Adams-Chapman I., Aucott S. W., Puopolo K. M., Goldsmith J. P., Kaufman D., Martin C., Mowitz M., Gonzalez L., Camenga D. R., Quigley J., Ryan S. A., Walker-Harding L; Committee on Fetus and Newborn, Committee on Substance Use and Prevention. (2020). Neonatal opioid withdrawal syndrome. Pediatrics, 146(5), 1–18. https://doi.org/10.1542/peds.2020-029074
doi: 10.1542/peds.2020-029074
Stringer K. L., Baker E. H. (2018). Stigma as a barrier to substance abuse treatment among those with unmet need: An analysis of parenthood and marital status. Journal of Family Issues, 39(1), 3–27. https://doi.org/10.1177/0192513X15581659
doi: 10.1177/0192513X15581659
Substance Abuse and Mental Health Services Administration. (2023). Evidence-based, whole-person care for pregnant people who have opioid use disorder. Advisory. Publication No. PEP23-02-01-002. https://store.samhsa.gov/sites/default/files/pep23-02-01-002.pdf
U.S. Department of Health and Human Services, Office of Inspector General. (2020). Geographic disparities affect access to buprenorphine services for opioid use disorder. https://oig.hhs.gov/oei/reports/oei-12-17-00240.asp